COMMUNIQUÉS West-GlobeNewswire

Delcath to Present at the RHK Capital 2018 Disruptive Growth and Healthcare Conference

04/05/2018 - 15:29

NEW YORK, May 04, 2018 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (OTCQB:DCTHD), an interventional oncology Company focused on the treatment of primary and metastatic liver cancers, announces that Jennifer K. Simpson, Ph [...]

Celsion Corporation to Hold First Quarter 2018 Financial Results Conference Call on Friday, May 11, 2018

04/05/2018 - 15:00

LAWRENCEVILLE, N.J., May 04, 2018 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ: CLSN) announced today that the Company will host a conference call to discuss financial results for the quarter ended March 31, 2018 and [...]

GBT Announces New Employment Inducement Grants

04/05/2018 - 14:30

SOUTH SAN FRANCISCO, Calif., May 04, 2018 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT ) today announced that on May 1, 2018, the compensation committee of the Company’s board of directors [...]

Verona Pharma to Present at Bio€quity Europe 2018

04/05/2018 - 14:30

LONDON, May 04, 2018 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM:VRP) (Nasdaq: VRNA ) (“Verona Pharma”), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for [...]

Tetra BioPharma Signs Second Commercialization Deal with Azevedos Industria Farmaceutica, S.A. for the Lead RX product PPP001

04/05/2018 - 14:26

OTTAWA, May 04, 2018 (GLOBE NEWSWIRE) -- Tetra Bio-Pharma Inc. (“Tetra” or the “Company”) (TSX-V: TBP ) (OTCQB:TBPMF), and Azevedos Indústria Farmacêutica, S.A. announced that they have signed a binding term sheet for [...]

Genocea to Host First Quarter 2018 Financial Results Conference Call & Webcast on May 10, 2018 at 9 a.m. ET

04/05/2018 - 14:04

CAMBRIDGE, Mass., May 04, 2018 (GLOBE NEWSWIRE) -- Genocea Biosciences, Inc. ( NASDAQ:GNCA), a biopharmaceutical company developing neoantigen cancer vaccines, today announced that it will host a conference call and [...]

Zogenix to Release First Quarter 2018 Financial Results and Host Conference Call and Webcast on May 9

04/05/2018 - 14:00

EMERYVILLE, Calif., May 04, 2018 (GLOBE NEWSWIRE) -- Zogenix, Inc. (NASDAQ: ZGNX ), a pharmaceutical company developing therapies for the treatment of rare central nervous system (CNS) disorders, today announced that it [...]

Capricor Therapeutics to Present First Quarter 2018 Financial Results and Corporate Update on May 10

04/05/2018 - 14:00

LOS ANGELES, May 04, 2018 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR ), a clinical-stage biotechnology company focused on the development of first-in-class biological therapeutics for the treatment of [...]

MediWound to Host First Quarter 2018 Financial Results Conference Call on May 10 at 8:30 a.m. Eastern Time

04/05/2018 - 14:00

YAVNE, Israel, May 04, 2018 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD ), a fully-integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn and wound management, [...]

Lexicon Pharmaceuticals Announces Publication of New XERMELO® (Telotristat Ethyl) Data in Clinical Therapeutics

04/05/2018 - 14:00

Significant Dose-Dependent Effects on Changes in Weight Gain and Biochemical and Metabolic Parameters Improvements in Diarrhea Severity and Nutritional Status THE WOODLANDS, Texas, May 04, 2018 (GLOBE NEWSWIRE) -- [...]

Intra-Cellular Therapies Announces Presentations on Lumateperone at Two Upcoming Medical Conferences

04/05/2018 - 14:00

NEW YORK, May 04, 2018 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI ), a biopharmaceutical company focused on the development of therapeutics for central nervous system (CNS) disorders, announced [...]

Avinger to Announce First Quarter 2018 Financial Results on May 14, 2018

04/05/2018 - 14:00

REDWOOD CITY, Calif., May 04, 2018 (GLOBE NEWSWIRE) -- Avinger, Inc. (Nasdaq: AVGR ), a leading developer of innovative treatments for peripheral artery disease (PAD), today announced that it will release its financial [...]

TG Therapeutics, Inc. to Host Conference Call on First Quarter 2018 Financial Results and Business Update

04/05/2018 - 13:30

Investor Conference Call to be held Tuesday, May 8, 2018 at 8:30am ET NEW YORK, May 04, 2018 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX ), today announced that a conference call will be held on Tuesday, May [...]

Flexion Therapeutics Announces ZILRETTA® (triamcinolone acetonide extended-release injectable suspension) Recommended for Unique J Code by CMS

04/05/2018 - 13:30

BURLINGTON, Mass., May 04, 2018 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq: FLXN ) today announced the Centers for Medicare and Medicaid Services (CMS) has included ZILRETTA (triamcinolone acetonide extended [...]

Achaogen Reports First Quarter 2018 Financial Results and Provides Corporate Update

04/05/2018 - 13:30

-- FDA Advisory Committee voted in favor of plazomicin for treatment of adults with complicated urinary tract infections -- -- Conference call today at 8:30 a.m. Eastern Time -- SOUTH SAN FRANCISCO, Calif., May 04, 2018 [...]

Trading by management and close relations of management

04/05/2018 - 13:14

Read the full announcement in the attached file Attachment 2018_25_Trading_by_management_EN

Myriad Genetics to Present Five Studies at the Seventh International Symposium on Hereditary Breast and Ovarian Cancer

04/05/2018 - 13:05

Presentations Highlight Continued Advancements in Hereditary Cancer Testing SALT LAKE CITY, May 04, 2018 (GLOBE NEWSWIRE) -- Myriad Genetics , Inc. (NASDAQ: MYGN ), a leader in molecular diagnostics and personalized [...]

Agios Provides Business Update on Discovery Research Strategy and Pipeline, Progress on Clinical Programs, Commercial Launch Preparations and Reports First Quarter 2018 Financial Results at Investor Day

04/05/2018 - 13:00

– Commercial Infrastructure In Place Ahead of August 21, 2018 PDUFA Action Date for TIBSOVO ® (Ivosidenib) for IDH1m R/R AML – – Clinical Portfolio Advancing with Four Compounds in Development and Five Pivotal Trials [...]

Lexington Announces Brokered Private Placement

04/05/2018 - 13:00

NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES AND DOES NOT CONSTITUTE AN OFFER OF THE SECURITIES DESCRIBED HEREIN VANCOUVER, B.C., May 04, 2018 (GLOBE NEWSWIRE) -- Lexington [...]